Loading investment pitches...
Equity Research Database
Institutional Investment Pitches
Explore thousands of hedge fund pitches, high-conviction equity research memos, and portfolio manager commentary extracted from quarterly letters.
Explore thousands of hedge fund pitches, high-conviction equity research memos, and portfolio manager commentary extracted from quarterly letters.
Moved lower due to drug pricing moderation fears and Q1 earnings coming below high expectations, but remains positioned for a sector re-rating.
— Fotis Chatzimichalakis, Sanjeev Lakhani, Luciano Lilloy
Full equity research memos, financial breakdowns, and hedge fund thesis write-ups are reserved for BSD Research ($50/mo) and Pro subscribers.
Already a Research or Pro subscriber? Sign In
Other investors who've written on Waters Corporation
No other institutional pitches found for this ticker yet.